View |
|
DR-XY43055
|
Mometasone furoate
|
Rynorex
|
50 mcg/ spray
|
Metered Dose Nasal Spray
|
Nasal Corticosteroid
|
Square Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
05 November 2023
|
05 December 2028
|
View |
|
DR-XY43060
|
Loratadine
|
Lordam
|
10mg
|
Tablet
|
Antihistamines (H1-Receptor Antagonists)
|
Nabiqasim Industries (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
25 May 2022
|
05 December 2026
|
View |
|
DR-XY43063
|
Carvedilol
|
Angicarv
|
12.5 mg
|
Tablet
|
Alpha and Beta-Blocker
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
19 December 2023
|
06 December 2028
|
View |
|
DR-XY43066
|
Salmeterol (as xinafoate) + Fluticasone propionate
|
Salmetide
|
50 mcg/500 mcg
|
Dry Powder for Inhalation
|
Beta-2 Adrenoceptor Agonist/ Corticosteroid
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
31 January 2019
|
09 December 2028
|
View |
|
DR-XY43067
|
Ceftizoxime (as sodium)
|
Sanzox
|
1 g
|
Powder For Injection (Iv/Im)
|
Antibacterial (Third Generation Cephalosporin)
|
Bharat Parentals Ltd.
|
India
|
Renewal
|
10 March 2024
|
09 December 2028
|
View |
|
DR-XY43079
|
Metformin Hydrochloride
|
Melmet SR 1000
|
1000 mg
|
Sustained Release Tablet
|
Oral Hypoglycemic ( Biguanide )
|
Micro Labs Limited
|
India
|
Renewal
|
12 February 2024
|
17 March 2029
|
View |
|
DR-XY43080
|
Metronidazole
|
MEDZOL
|
5mg/ml(500mg/100ml)
|
Solution for IV Infusion
|
Antibacterial (Imidazole)
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
10 May 2022
|
17 March 2027
|
View |
|
DR-XY43082
|
Zinc (as Zinc Sulfate Monohydrate)
|
Unbranded
|
10 mg per mL
|
Syrup Equivalent To 10 Mg Elemental Zinc)
|
Mineral
|
Northfield Laboratories., Inc.
|
Philippines
|
Renewal
|
04 January 2019
|
17 December 2028
|
View |
|
DR-XY43096
|
Lacosamide
|
Vimpat
|
50mg
|
Film-Coated Tablet
|
Antiepileptic
|
Aesica Pharmaceuticals GmbH
|
Germany
|
Renewal
|
19 December 2023
|
22 January 2029
|
View |
|
DR-XY43105
|
Dimenhydrinate + Cinnarizine
|
Dimezine
|
40mg / 20mg
|
Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
Automatic Renewal
|
25 October 2023
|
19 December 2028
|
View |
|
DR-XY43106
|
Montelukast (as sodium) + Cetirizine hydrochloride
|
Alduet
|
10 mg / 10 mg
|
Film-Coated Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
Automatic Renewal
|
05 October 2023
|
19 December 2028
|
View |
|
DR-XY43108
|
Lansoprazole
|
Lanvell
|
30 mg
|
Capsule
|
Proton Pump Inhibitor
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Automatic Renewal
|
11 February 2023
|
19 December 2028
|
View |
|
DR-XY43110
|
Levetiracetam
|
Unbranded
|
500 mg
|
Film-Coated Tablet
|
Anti-epileptic
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
17 August 2023
|
19 December 2028
|
View |
|
DR-XY43111
|
Levetiracetam
|
Levetra
|
500 mg
|
Film-Coated Tablet
|
Anti-epileptic
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
15 February 2024
|
19 December 2028
|
View |
|
DR-XY43112
|
Levetiracetam
|
Epsytam
|
500 mg
|
Film-Coated Tablet
|
Anti-epileptic
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
28 August 2023
|
19 December 2028
|
View |
|
DR-XY43121
|
Prednisolone
|
Neopred
|
20 mg
|
Tablet
|
Corticosteriod
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 October 2023
|
08 January 2029
|
View |
DR-XY43123_PI_01_NO RX SYMBOL.pdf
|
DR-XY43123
|
Dexamethasone
|
Unbranded
|
700mcg
|
Sustained Release Sterile Rod-Shaped Implant For Ophthalmic Intravitreal Injection
|
Anti-inflammatory Agent (Corticosteroid)
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Renewal
|
29 June 2020
|
08 January 2029
|
View |
|
DR-XY43127
|
Sildenafil (as Citrate)
|
Hydenex
|
50 mg
|
Tablet
|
Phosphodiesterase Type 5 Inhibitor
|
Compact Pharmaceuticals Corp
|
Philippines
|
Renewal
|
15 March 2024
|
20 February 2029
|
View |
|
DR-XY43129
|
Naproxen
|
Unbranded
|
500 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
03 December 2023
|
11 February 2029
|
View |
|
DR-XY43135
|
Salmeterol (as xinafoate) + Fluticasone Propionate
|
Adeflo
|
50 mcg/250 mcg
|
Dry Powder Inhalation Capsule
|
Adrenergic in combination with corticosteroid or other drug, excluding anticholinergic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
31 October 2023
|
20 February 2029
|